PT Millennium Pharmacon International Tbk (SDPC.JK)
IDR 132.0
(0.76%)
IDR 132.0
(0.76%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3363.51 Billion IDR | 5.08% |
| 2022 | 3200.83 Billion IDR | 7.09% |
| 2021 | 2988.84 Billion IDR | 13.06% |
| 2020 | 2643.62 Billion IDR | -3.05% |
| 2019 | 2726.75 Billion IDR | 14.75% |
| 2018 | 2376.18 Billion IDR | 12.57% |
| 2017 | 2110.82 Billion IDR | 7.14% |
| 2016 | 1970.11 Billion IDR | 15.37% |
| 2015 | 1707.61 Billion IDR | 18.78% |
| 2014 | 1437.66 Billion IDR | 9.73% |
| 2013 | 1310.24 Billion IDR | 11.7% |
| 2012 | 1172.97 Billion IDR | 20.53% |
| 2011 | 973.21 Billion IDR | 16.28% |
| 2010 | 836.96 Billion IDR | -17.21% |
| 2009 | 1010.93 Billion IDR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 983.82 Billion IDR | 1.79% |
| 2024 Q2 | 966.55 Billion IDR | -0.74% |
| 2024 Q1 | 973.73 Billion IDR | 5.41% |
| 2023 Q1 | 753.58 Billion IDR | -6.67% |
| 2023 FY | 3363.51 Billion IDR | 5.08% |
| 2023 Q4 | 923.72 Billion IDR | 5.75% |
| 2023 Q3 | 873.52 Billion IDR | 7.49% |
| 2023 Q2 | 812.67 Billion IDR | 7.84% |
| 2022 Q3 | 845.51 Billion IDR | 15.13% |
| 2022 Q4 | 807.44 Billion IDR | -4.5% |
| 2022 Q1 | 813.45 Billion IDR | 13.39% |
| 2022 FY | 3200.83 Billion IDR | 7.09% |
| 2022 Q2 | 734.41 Billion IDR | -9.72% |
| 2021 Q2 | 744.63 Billion IDR | 8.9% |
| 2021 FY | 2988.84 Billion IDR | 13.06% |
| 2021 Q4 | 717.41 Billion IDR | -14.9% |
| 2021 Q3 | 843 Billion IDR | 13.21% |
| 2021 Q1 | 683.78 Billion IDR | -1.33% |
| 2020 FY | 2643.62 Billion IDR | -3.05% |
| 2020 Q4 | 693.02 Billion IDR | 15.39% |
| 2020 Q1 | 785.28 Billion IDR | 12.18% |
| 2020 Q2 | 564.72 Billion IDR | -28.09% |
| 2020 Q3 | 600.59 Billion IDR | 6.35% |
| 2019 Q2 | 666.41 Billion IDR | -1.69% |
| 2019 FY | 2726.75 Billion IDR | 14.75% |
| 2019 Q1 | 677.88 Billion IDR | 6.5% |
| 2019 Q4 | 699.99 Billion IDR | 2.57% |
| 2019 Q3 | 682.45 Billion IDR | 2.41% |
| 2018 Q3 | 625.66 Billion IDR | 11.47% |
| 2018 FY | 2376.18 Billion IDR | 12.57% |
| 2018 Q1 | 552.71 Billion IDR | 0.59% |
| 2018 Q2 | 561.28 Billion IDR | 1.55% |
| 2018 Q4 | 636.51 Billion IDR | 1.73% |
| 2017 FY | 2110.82 Billion IDR | 7.14% |
| 2017 Q1 | 502.15 Billion IDR | -0.22% |
| 2017 Q2 | 505.09 Billion IDR | 0.59% |
| 2017 Q3 | 554.1 Billion IDR | 9.7% |
| 2017 Q4 | 549.46 Billion IDR | -0.84% |
| 2016 Q1 | 479.28 Billion IDR | 5.46% |
| 2016 FY | 1970.11 Billion IDR | 15.37% |
| 2016 Q4 | 503.27 Billion IDR | 6.81% |
| 2016 Q3 | 471.19 Billion IDR | -8.74% |
| 2016 Q2 | 516.35 Billion IDR | 7.73% |
| 2015 Q2 | 429.28 Billion IDR | 6.66% |
| 2015 Q1 | 402.48 Billion IDR | 4.13% |
| 2015 FY | 1707.61 Billion IDR | 18.78% |
| 2015 Q4 | 454.47 Billion IDR | 7.86% |
| 2015 Q3 | 421.36 Billion IDR | -1.85% |
| 2014 Q1 | 342.67 Billion IDR | 0.52% |
| 2014 FY | 1437.66 Billion IDR | 9.73% |
| 2014 Q3 | 357.37 Billion IDR | 1.79% |
| 2014 Q2 | 351.09 Billion IDR | 2.46% |
| 2014 Q4 | 386.52 Billion IDR | 8.16% |
| 2013 Q3 | 334.6 Billion IDR | 3.32% |
| 2013 Q2 | 323.85 Billion IDR | 4.17% |
| 2013 Q4 | 340.89 Billion IDR | 1.88% |
| 2013 FY | 1310.24 Billion IDR | 11.7% |
| 2013 Q1 | 310.88 Billion IDR | 2.3% |
| 2012 FY | 1172.97 Billion IDR | 20.53% |
| 2012 Q3 | 292.18 Billion IDR | 0.0% |
| 2012 Q4 | 303.88 Billion IDR | 4.01% |
| 2011 FY | 973.21 Billion IDR | 16.28% |
| 2010 FY | 836.96 Billion IDR | -17.21% |
| 2009 FY | 1010.93 Billion IDR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 28507.87 Billion IDR | 88.201% |
| PT Itama Ranoraya Tbk | 696.3 Billion IDR | -383.053% |
| PT Kimia Farma (Persero) Tbk | 9965.03 Billion IDR | 66.247% |
| PT Soho Global Health Tbk | 8197.75 Billion IDR | 58.97% |